A class-action lawsuit was filed last week against CVS Caremark in the Southern District of New York over its decision to replace Eli Lilly’s popular GLP-1 weight-loss drug Zepbound with Wegovy from Novo Nordisk.

The plaintiffs alleged that the company and State Street Global Advisors violated fiduciary requirements under the Employee Retirement Income Security Act.

The long-awaited proposal, designed to incentivize Musk to lead Tesla for years to come, sets a series of ambitious benchmarks he must meet to earn the full payout, including expanding Tesla’s nascent robotaxi business and growing the company’s market value to at least $8.5 trillion from about $1.1 trillion today.